Selected Cell
Cell:
Value:
Description
Metadata
Codes
Immunizations (TAB. 1)
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| Title | Immunizations | ||||||||
| Overview | Informationen über die Immunisierung verschiedener Patienten in einem Zeitraum zwischen 1945 und 2020 mit unterschiedlichen Impfstoffen. Der vollständige Datensatz ist ein Auszug aus der Synthea-Datenbank, welche die vollständige Krankengeschichte, Medikamente, Allergien, medizinischen Begegnungen und sozialen Determinanten der Gesundheit fiktiver Patienten enthält. Die Patientenmodelle stammen dabei aus modellierten Ereignissen und beschreiben einen Verlauf von Zuständen und die Übergänge zwischen diesen. Die Modelle wurden anhand realer Statistiken übernommen, welche von CDC, NIH und anderen Forschungsquellen stammen. Der Beispieldatensatz wurde im Rahmen des BIDS Kurses “Forschungsdatenmanagement” von Sarah Braun in Form einer Excel-Tabelle (.xlsx) zur Verfügung gestellt. | ||||||||
| Restrictions | Die Synthea Software steht unter der Apache License, Version 2.0. Eine Sekundärnutzung der generierten Daten ist ohne Einschränkung möglich, z.B. in Wissenschaft, Forschung, Industrie oder Politik, unter einer Creative Commons Attribution-ShareAlike 4.0 International License. | ||||||||
| Source | Synthea-Datenbank (https://synthetichealth.github.io/synthea/, https://doi.org/10.1093/jamia/ocx079) | ||||||||
| Source Format | HL7 FHIR®, C-CDA und CSV - Umwandlung in xlsx | ||||||||
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| Feld | Inhalt / Beschreibung | Format | Referenz | Terminologie | |||||
| DATE | Datum + Uhrzeit | DATE ISO8601 (YYYY-MM-DD HH:MM:SS) Range 1945-09-05T00:20:08Z - 2020-04-28T18:58:37Z | https://www.iso.org/iso-8601-date-and-time-format.html | ||||||
| PATIENT | Codierung des Patienten | STRING (UUID) | https://www.rfc-editor.org/info/rfc4122 | ||||||
| ENCOUNTER | Codierung des Patientenkontakts | STRING (UUID) | https://www.rfc-editor.org/info/rfc4122 | ||||||
| CODE | Kenncode der Impfung | INTEGER | https://www.hl7.org/fhir/valueset-vaccine-code.html | ||||||
| DESCRIPTION | Beschreibung der Impfung | STRING | https://www.hl7.org/fhir/valueset-vaccine-code.html | ||||||
| BASE_COST | Kosten der Impfung | FLOAT (140.52 für alle Tupel) | |||||||
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| CODE | DESCRIPTION | ||||||||
| 3 | MMR | ||||||||
| 8 | Hep B adolescent or pediatric | ||||||||
| 10 | IPV | ||||||||
| 20 | DTaP | ||||||||
| 21 | varicella | ||||||||
| 33 | pneumococcal polysaccharide vaccine 23 valent | ||||||||
| 43 | Hep B adult | ||||||||
| 49 | Hib (PRP-OMP) | ||||||||
| 52 | Hep A adult | ||||||||
| 62 | HPV quadrivalent | ||||||||
| 83 | Hep A ped/adol 2 dose | ||||||||
| 113 | Td (adult) preservative free | ||||||||
| 114 | meningococcal MCV4P | ||||||||
| 115 | Tdap | ||||||||
| 119 | rotavirus monovalent | ||||||||
| 121 | zoster | ||||||||
| 133 | Pneumococcal conjugate PCV 13 | ||||||||
| 140 | Influenza seasonal injectable preservative free | ||||||||
A
B
C
D
E
F
G
H
I
J
9101
9102
9103
9104
9105
9106
9107
9108
9109
9110
9111
9112
9113
9114
9115
9116
9117
9118
9119
9120
9121
9122
9123
9124
9125
9126
9127
9128
9129
9130
9131
9132
9133
9134
9135
9136
9137
9138
9139
9140
9141
9142
9143
9144
9145
9146
9147
9148
9149
9150
9151
9152
9153
9154
9155
9156
9157
9158
9159
9160
9161
9162
9163
9164
9165
9166
9167
9168
9169
9170
9171
9172
9173
9174
9175
9176
9177
9178
9179
9180
9181
9182
9183
9184
9185
9186
9187
9188
9189
9190
9191
9192
9193
9194
9195
9196
9197
9198
9199
9200
| 2013-01-01T03:09:55Z | 3e66977b-83ab-433e-9cd5-91b6ea2019a3 | 92bfc3a0-47d8-469b-a651-258825b5319f | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2016-01-05T03:09:55Z | 3e66977b-83ab-433e-9cd5-91b6ea2019a3 | 063d17e2-a199-4a36-94fb-8f9a78a63bb1 | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2018-10-23T03:09:55Z | 3e66977b-83ab-433e-9cd5-91b6ea2019a3 | 655068a7-e49a-4f98-a206-17d8c1783a12 | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2018-10-23T03:09:55Z | 3e66977b-83ab-433e-9cd5-91b6ea2019a3 | 655068a7-e49a-4f98-a206-17d8c1783a12 | 52 | Hep A adult | 140.52 | ||||
| 2016-07-16T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 4abac253-a941-4a89-9b43-3baeab6bf61b | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2016-08-20T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 77b2cdcf-b907-43bf-8211-1f361a4c118d | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2016-10-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | b4a82213-4f41-494d-bb03-e6dc0b0195a2 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2016-10-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | b4a82213-4f41-494d-bb03-e6dc0b0195a2 | 119 | rotavirus monovalent | 140.52 | ||||
| 2016-10-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | b4a82213-4f41-494d-bb03-e6dc0b0195a2 | 10 | IPV | 140.52 | ||||
| 2016-10-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | b4a82213-4f41-494d-bb03-e6dc0b0195a2 | 20 | DTaP | 140.52 | ||||
| 2016-10-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | b4a82213-4f41-494d-bb03-e6dc0b0195a2 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2016-12-24T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 5d101782-5843-4491-b547-85f2c17a4586 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2016-12-24T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 5d101782-5843-4491-b547-85f2c17a4586 | 119 | rotavirus monovalent | 140.52 | ||||
| 2016-12-24T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 5d101782-5843-4491-b547-85f2c17a4586 | 10 | IPV | 140.52 | ||||
| 2016-12-24T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 5d101782-5843-4491-b547-85f2c17a4586 | 20 | DTaP | 140.52 | ||||
| 2016-12-24T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 5d101782-5843-4491-b547-85f2c17a4586 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-03-25T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 2df65bcf-606a-4d7c-ba76-1c942fa2eaf0 | 10 | IPV | 140.52 | ||||
| 2017-03-25T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 2df65bcf-606a-4d7c-ba76-1c942fa2eaf0 | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2017-03-25T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 2df65bcf-606a-4d7c-ba76-1c942fa2eaf0 | 20 | DTaP | 140.52 | ||||
| 2017-03-25T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 2df65bcf-606a-4d7c-ba76-1c942fa2eaf0 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-03-25T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 2df65bcf-606a-4d7c-ba76-1c942fa2eaf0 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2017-09-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | e8073d8b-52a1-4309-9ca2-f59ac58763c4 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2017-09-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | e8073d8b-52a1-4309-9ca2-f59ac58763c4 | 21 | varicella | 140.52 | ||||
| 2017-09-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | e8073d8b-52a1-4309-9ca2-f59ac58763c4 | 3 | MMR | 140.52 | ||||
| 2017-09-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | e8073d8b-52a1-4309-9ca2-f59ac58763c4 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-09-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | e8073d8b-52a1-4309-9ca2-f59ac58763c4 | 83 | Hep A ped/adol 2 dose | 140.52 | ||||
| 2017-12-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 86e493d3-c14a-4f6f-aa64-14b29cbc9ad2 | 20 | DTaP | 140.52 | ||||
| 2018-06-23T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | bcab188e-032f-4c0a-9014-3fec2a061f3a | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2018-12-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | f9c86cf4-db1b-4f80-9c41-52096aaacc2c | 83 | Hep A ped/adol 2 dose | 140.52 | ||||
| 2019-06-22T07:51:15Z | 3f42f2e3-6f63-47d2-aac8-ee1f12271b47 | 81ecad17-9bbf-4297-ba42-b1682970224a | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2018-07-01T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 974a582b-3cf5-402a-93c5-14f136d1c6f2 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2018-08-05T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | a20b9c23-b8ba-44be-8025-6924f2305033 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2018-10-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | c132fa1d-5cc6-45ab-9240-da3e0b9e89ef | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2018-10-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | c132fa1d-5cc6-45ab-9240-da3e0b9e89ef | 119 | rotavirus monovalent | 140.52 | ||||
| 2018-10-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | c132fa1d-5cc6-45ab-9240-da3e0b9e89ef | 10 | IPV | 140.52 | ||||
| 2018-10-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | c132fa1d-5cc6-45ab-9240-da3e0b9e89ef | 20 | DTaP | 140.52 | ||||
| 2018-10-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | c132fa1d-5cc6-45ab-9240-da3e0b9e89ef | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2018-12-09T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 8da55bcc-40a6-45b1-b0f8-54cf3e5e8a36 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2018-12-09T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 8da55bcc-40a6-45b1-b0f8-54cf3e5e8a36 | 119 | rotavirus monovalent | 140.52 | ||||
| 2018-12-09T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 8da55bcc-40a6-45b1-b0f8-54cf3e5e8a36 | 10 | IPV | 140.52 | ||||
| 2018-12-09T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 8da55bcc-40a6-45b1-b0f8-54cf3e5e8a36 | 20 | DTaP | 140.52 | ||||
| 2018-12-09T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 8da55bcc-40a6-45b1-b0f8-54cf3e5e8a36 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-03-10T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | d454b141-dc52-4fe3-90af-e5020466e41c | 10 | IPV | 140.52 | ||||
| 2019-03-10T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | d454b141-dc52-4fe3-90af-e5020466e41c | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2019-03-10T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | d454b141-dc52-4fe3-90af-e5020466e41c | 20 | DTaP | 140.52 | ||||
| 2019-03-10T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | d454b141-dc52-4fe3-90af-e5020466e41c | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-03-10T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | d454b141-dc52-4fe3-90af-e5020466e41c | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2019-07-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 713ace1b-67b0-406e-879e-db58e1db1ef2 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2019-07-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 713ace1b-67b0-406e-879e-db58e1db1ef2 | 21 | varicella | 140.52 | ||||
| 2019-07-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 713ace1b-67b0-406e-879e-db58e1db1ef2 | 3 | MMR | 140.52 | ||||
| 2019-07-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 713ace1b-67b0-406e-879e-db58e1db1ef2 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-07-07T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | 713ace1b-67b0-406e-879e-db58e1db1ef2 | 83 | Hep A ped/adol 2 dose | 140.52 | ||||
| 2019-12-08T15:57:06Z | 9b50f7b9-c67c-4044-aad0-594ee95b0c29 | e0884db4-2f54-47cb-9d88-3c708e5209dd | 20 | DTaP | 140.52 | ||||
| 2018-09-05T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | ac994610-c040-4c5c-a281-7828fd5c5207 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2018-10-10T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | a90fa6ad-e469-4c00-8d6a-5a7d9bb786a9 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2018-12-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 3256dc11-9823-428f-a241-2724c77367bc | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2018-12-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 3256dc11-9823-428f-a241-2724c77367bc | 119 | rotavirus monovalent | 140.52 | ||||
| 2018-12-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 3256dc11-9823-428f-a241-2724c77367bc | 10 | IPV | 140.52 | ||||
| 2018-12-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 3256dc11-9823-428f-a241-2724c77367bc | 20 | DTaP | 140.52 | ||||
| 2018-12-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 3256dc11-9823-428f-a241-2724c77367bc | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-02-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 1db6626a-a6ed-4496-a622-6a56e8b9ae07 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2019-02-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 1db6626a-a6ed-4496-a622-6a56e8b9ae07 | 119 | rotavirus monovalent | 140.52 | ||||
| 2019-02-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 1db6626a-a6ed-4496-a622-6a56e8b9ae07 | 10 | IPV | 140.52 | ||||
| 2019-02-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 1db6626a-a6ed-4496-a622-6a56e8b9ae07 | 20 | DTaP | 140.52 | ||||
| 2019-02-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 1db6626a-a6ed-4496-a622-6a56e8b9ae07 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-05-15T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | bee9e944-f734-4944-81db-ae1c4bf20d23 | 10 | IPV | 140.52 | ||||
| 2019-05-15T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | bee9e944-f734-4944-81db-ae1c4bf20d23 | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2019-05-15T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | bee9e944-f734-4944-81db-ae1c4bf20d23 | 20 | DTaP | 140.52 | ||||
| 2019-05-15T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | bee9e944-f734-4944-81db-ae1c4bf20d23 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-05-15T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | bee9e944-f734-4944-81db-ae1c4bf20d23 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2019-11-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 75390258-5c91-402f-987b-e3c25afc5ea9 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2019-11-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 75390258-5c91-402f-987b-e3c25afc5ea9 | 21 | varicella | 140.52 | ||||
| 2019-11-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 75390258-5c91-402f-987b-e3c25afc5ea9 | 3 | MMR | 140.52 | ||||
| 2019-11-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 75390258-5c91-402f-987b-e3c25afc5ea9 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2019-11-13T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | 75390258-5c91-402f-987b-e3c25afc5ea9 | 83 | Hep A ped/adol 2 dose | 140.52 | ||||
| 2020-02-12T05:56:40Z | 97e25dc6-10bd-4ad2-9269-6e33b61870dc | b1c3ddcc-601a-487b-a18f-18b54c4da8cf | 20 | DTaP | 140.52 | ||||
| 2017-03-06T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 816a29f1-46d6-4697-8d54-2686168663aa | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2017-04-10T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 7431e15f-78b8-49c7-a847-d54466d22725 | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2017-06-12T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | b623852a-9d80-453d-93c7-109a4e88f96f | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2017-06-12T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | b623852a-9d80-453d-93c7-109a4e88f96f | 119 | rotavirus monovalent | 140.52 | ||||
| 2017-06-12T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | b623852a-9d80-453d-93c7-109a4e88f96f | 10 | IPV | 140.52 | ||||
| 2017-06-12T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | b623852a-9d80-453d-93c7-109a4e88f96f | 20 | DTaP | 140.52 | ||||
| 2017-06-12T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | b623852a-9d80-453d-93c7-109a4e88f96f | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-08-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 113c549c-dbc3-48f7-9e49-45df3b612b19 | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2017-08-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 113c549c-dbc3-48f7-9e49-45df3b612b19 | 119 | rotavirus monovalent | 140.52 | ||||
| 2017-08-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 113c549c-dbc3-48f7-9e49-45df3b612b19 | 10 | IPV | 140.52 | ||||
| 2017-08-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 113c549c-dbc3-48f7-9e49-45df3b612b19 | 20 | DTaP | 140.52 | ||||
| 2017-08-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 113c549c-dbc3-48f7-9e49-45df3b612b19 | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-11-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 0ffa028e-6aa1-4a20-86d0-6ff8de435cbc | 10 | IPV | 140.52 | ||||
| 2017-11-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 0ffa028e-6aa1-4a20-86d0-6ff8de435cbc | 140 | Influenza seasonal injectable preservative free | 140.52 | ||||
| 2017-11-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 0ffa028e-6aa1-4a20-86d0-6ff8de435cbc | 20 | DTaP | 140.52 | ||||
| 2017-11-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 0ffa028e-6aa1-4a20-86d0-6ff8de435cbc | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2017-11-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 0ffa028e-6aa1-4a20-86d0-6ff8de435cbc | 8 | Hep B adolescent or pediatric | 140.52 | ||||
| 2018-05-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 157c3cc7-f350-47d5-a452-5419d85d505a | 49 | Hib (PRP-OMP) | 140.52 | ||||
| 2018-05-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 157c3cc7-f350-47d5-a452-5419d85d505a | 21 | varicella | 140.52 | ||||
| 2018-05-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 157c3cc7-f350-47d5-a452-5419d85d505a | 3 | MMR | 140.52 | ||||
| 2018-05-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 157c3cc7-f350-47d5-a452-5419d85d505a | 133 | Pneumococcal conjugate PCV 13 | 140.52 | ||||
| 2018-05-14T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 157c3cc7-f350-47d5-a452-5419d85d505a | 83 | Hep A ped/adol 2 dose | 140.52 | ||||
| 2018-08-13T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 08c62503-acb7-46fd-bf44-65b8efea86fa | 20 | DTaP | 140.52 | ||||
| 2019-02-11T14:46:34Z | 3335451e-608b-493a-9560-f0a05dd50b17 | 4607e10d-1b10-4880-96eb-77cb3d629036 | 140 | Influenza seasonal injectable preservative free | 140.52 |
